The Scotland-based drug delivery device developer cited limited inhalable medicine development due to a number of reasons. Those include accessibility, cost, performance and environmental impact. Its own development could enable the delivery of several dry powder drugs in a sustainable, low-cost delivery device.
Rather than use expensive, bulky plastic, 1nhaler uses cardboard to create an inhaler with the same dimensions as a credit card. The discreet platform features a breathable membrane capable of tailoring to deliver individual drugs to patients.
Get the full story at our sister site, Drug Delivery Business News.
